WHO advises against Gilead's remdesivir for all hospitalised COVID-19 patientsOn Friday, a World Health Organisation guidelines panel advised against using the antiviral remdesivir for hospitalised patients, saying th...
21 Nov, 2020, 08.16 AM IST
DCGI rejects Dr Reddy's proposal seeking change in regulatory approval status for remdesivirDr Reddy’s had approached the Subject Expert committee (SEC) that advises the Drug Controller General of India (DCGI) on applications seeki...
02 Nov, 2020, 06.24 PM IST
National task force for Covid-19 to review use of RemdesivirThe experts will also review evidence on anti-parasitic drug ivermectin. “The task force will review the overall Covid situation. Along wit...
22 Oct, 2020, 08.24 AM IST
Remdesivir use may continue in India as few options in sightDoctors say they find Remdesivir helps reduce viral load in moderate cases. Some, however, question its effectiveness and price. They have ...
20 Oct, 2020, 08.32 AM IST
ICMR approaches experts panel to approve testing of cancer drug acalabrutinib for Covid treatmentICMR’s National AIDS Research Institute (NARI) had presented a proposal to the Subject Expert Committee (SEC) formed to review Covid relate...
19 Oct, 2020, 05.56 PM IST
India to review use of remdesivir, hydroxychloroquine for Covid therapyIndian Council of Medical Research (ICMR) director general Balram Bhargava told ET that clinical protocols will be updated after discussion...
17 Oct, 2020, 08.12 AM IST
WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patientsThe study found the regimens appeared to have little or no effect on 28-day mortality or the length of the in-hospital course among patient...
16 Oct, 2020, 09.46 AM IST
There may never be a 'silver bullet' for COVID-19, WHO warnsWHO Director-General Tedros Adhanom Ghebreyesus and WHO emergencies head Mike Ryan exhorted all nations to rigorously enforce health measur...
03 Aug, 2020, 09.51 PM IST
WHO's decision to resume HCQ clinical trial a step in right direction, say expertsThe global heath body had earlier suspended the hydroxychloroquine (HCQ) arm of the clinical trials of experimental COVID-19 drugs over saf...
04 Jun, 2020, 04.17 PM IST
India's drug regulator grants Gilead Sciences marketing authorisation for remdesivirThe approval process for remdesivir was accelerated in view of the emergency situation and the unmet need for medicines in light of the cor...
02 Jun, 2020, 12.46 PM IST
US pharma giant seeks marketing authorisation from India for remdesivir"Gilead Sciences has applied seeking marketing authorisation for its anti-viral drug remdesivir to India's Central Drugs Standard Control O...
30 May, 2020, 10.28 AM IST
US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in IndiaOfficials of the Union Health Ministry, along with the Drugs Controller General of India (DCGI) held a discussion with the representatives ...
21 May, 2020, 05.51 PM IST
India to test four drugs for Covid-19 as part of the WHO solidarity trialOn Wednesday the Indian Council of Medical Research (ICMR) announced that potential anti-viral agents, Remdesivir, Chloroquine/Hydroxychlor...
15 May, 2020, 03.35 PM IST
WHO trial is on fast track in India: Sheela Godbole, Senior Scientist, National Aids Research InstituteIndia plans to run the trial on 1,500 patients across 20-30 sites, Sheela Godbole, chief scientist at National AIDS Research Institute and ...
14 May, 2020, 11.36 PM IST
India to test four drugs as part of WHO trialPotential anti-viral agents remdesivir, chloroquine/hydroxychloroquine, lopinavir-ritonavir and lopinavir-ritonavir with interferon will be...
14 May, 2020, 06.56 AM IST
ICMR may use remdesivir if local companies can manufacture itThe Indian Council of Medical Research (ICMR) said it will consider using remdesivir, an experimental drug made by Gilead Sciences, to trea...
14 Apr, 2020, 07.04 AM IST
Aid groups plan to widen Covid-19 trial baseA global coalition of aid organisations, government agencies and academic institutions will facilitate the clinical trials of Covid-19 drug...
04 Apr, 2020, 08.38 AM IST